Search Results
Does the energy transfer from Ar(1s) atoms to N2 lead to dissociation?
Dielectric-barrier discharges (DBDs) in Ar–N2 mixtures, with N2 fractions in 0.1–1% range, would be attractive alternatives to DBDs in pure N2 if energy-transfer reactions between Ar(1s) atoms and N2 molecules were an efficient source of N atoms. Attempts to functionalize polyolefins in flowing postdischarges fed by such DBDs, as well as the search for the First Positive System in the emission spectrum, however, failed. Evidently, the energy-transfer reactions do not produce N atoms. For Ar(1s3) and Ar(1s5) metastable states, this fact has already been reported in the literature. For Ar(1s2) and Ar(1s4) resonant states, a quantitative argument is derived in this paper: energy transfer from Ar(1s) atoms to N2 molecules is not an efficient source of N atoms.
HelixJet: An innovative plasma source for next-generation additive manufacturing (3D printing)
A novel plasma source (HelixJet) for use in additive manufacturing (AM)/3D printing is proposed. The HelixJet is a capacitively coupled radio frequency plasma with a double-helix electrode configuration that generates a surprisingly stable and homogeneous glow plasma at low flow rates of argon and its mixtures at atmospheric pressure. The HelixJet was tested on three polyamide powders usually used to produce parts by laser sintering, a powder-based AM process, to form local deposits. The chemical composition of such plasma-printed samples is compared with thermally produced and laser-sintered samples with respect to differences in morphology that result from the different thermal cycles on several length scales. Plasma prints exhibit unique features attributable to the nonequilibrium chemistry and to the high-speed heat exchange.
Oral SARS-CoV-2 reduction by local treatment: A plasma technology application?
The SARS-CoV-2 pandemic reemphasized the importance of and need for efficient hygiene and disinfection measures. The coronavirus' efficient spread capitalizes on its airborne transmission routes via virus aerosol release from human oral and nasopharyngeal cavities. Besides the upper respiratory tract, efficient viral replication has been described in the epithelium of these two body cavities. To this end, the idea emerged to employ plasma technology to locally reduce mucosal viral loads as an additional measure to reduce patient infectivity. We here outline conceptual ideas of such treatment concepts within what is known in the antiviral actions of plasma treatment so far.
Zebrafish larvae as a toxicity model in plasma medicine
Plasma technology has emerged as a promising tool in medicine that, however, requires not only efficacy but also toxicological assessments. Traditional cell culture systems are fast and economical, but they lack in vivo relevance; however, rodent models are highly complex and necessitate extended facilities. Zebrafish larvae bridge this gap, and many larvae can be analyzed in well plates in a single run, giving results in 1–2 days. Using the kINPen, we found plasma exposure to reduce hedging rates and viability in a dose-dependent manner, accompanied with an increase in reactive oxygen species and a decrease of glutathione in plasma-treated fish. Modest growth alterations were also observed. Altogether, zebrafish larvae constitute a fast, reliable, and relevant model for testing the toxicity of plasma sources.
Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma
The prognosis of patients suffering from advanced-stage head and neck squamous cell carcinoma (HNSCC) remains poor. Medical gas plasma therapy receives growing attention as a novel anticancer modality. Our recent prospective observational study on HNSCC patients suffering from contaminated tumor ulcerations without lasting remission after first-line anticancer therapy showed remarkable efficacy of gas plasma treatment, with the ulcerated tumor surface decreasing by up to 80%. However, tumor growth relapsed, and this biphasic response may be a consequence of immunological and molecular changes in the tumor microenvironment that could be caused by (a) immunosuppression, (b) tumor cell adaption, (c) loss of microbe-induced immunostimulation, and/or (d) stromal cell adaption. These considerations may be vital for the design of clinical plasma trials in the future.
From patent to product? 50 years of low-pressure plasma sterilization
The development of new sterilization methods is still a major topic. The need for new techniques arises from the development of new instruments and the usage of different materials. Especially in the case of plastics with their beneficial properties, for example, in the field of implantology, plasma sterilization is seen as a promising alternative to the standard methods. However, 50 years after the first patent and although low-pressure plasmas show excellent inactivation performance (>log 6 reduction), only one commercial system is available on the market for a distinct application. We will give a short review about known plasma sterilization mechanisms, the different plasma sterilization systems in use, analyze possible challenges for an industrial process and comment on possible solutions for a broader acceptance and utilization of low-pressure plasma sterilization.
White paper on plasma for medicine and hygiene: Future in plasma health sciences
Plasma Science and Technology offer their valuable contribution to human health since more than 50 years, after decades of experiences in the field of biomaterials; and more than a decade in using plasmas for therapeutic uses in medicine. Current knowledge as well as key challenges and opportunities for the human health have been intensely discussed during the Future in Plasma Science II (FIPS II) workshop in February 2016 in Greifswald, Germany. This contribution summarizes the major outcomes of the meeting and the current literature and consensus with an emphasis on major challenges in the fields of Plasma Science and Technology for improving human health.
Efficiency of plasma-processed air for biological decontamination of crop seeds on the premise of unimpaired seed germination
In this study, the antimicrobial effect of plasma-processed air (PPA) generated by a microwave-induced nonthermal plasma was investigated for preharvest utilization using three crop species: Barley, rape, and lupine. Bacillus atrophaeus spores were chosen as a model, inoculated onto seeds, and subsequently treated with PPA at two different flow rates, different filling regimes, and gas exposure times. PPA treatment was efficient in reducing viable spores of B. atrophaeus, reaching sporicidal effects in all species at certain parameter combinations. Maximum germination of seeds was strongly reduced in barley and rape seeds at some parameter combination, whereas it had a modest effect on lupine seeds. Seed hydrophilicity was not altered. Overall, PPA investigated in this study proved suitable for preharvest applications.
Effect of cold atmospheric pressure plasma treatment of eggshells on the total bacterial count inoculated Salmonella Enteritidis and selected quality parameters
In the European Union, foodborne outbreaks caused by Salmonella Enteritidis, related to eggs and egg products, have even been reported in 2018. Atmospheric pressure plasma is becoming increasingly important as a decontamination method. A semidirect cold atmospheric pressure plasma, the flexible electrode plasma source, was developed for treating whole hen's eggs. An average reduction of 1.16 and 0.95 log colony-forming units (CFU)/egg was achieved for the total bacterial count of clean and dirty eggs, respectively. An inactivation of 4.1 log CFU/egg Salmonella Enteritidis was achieved with artificially inoculated eggshells. Selected quality parameters and sensory properties were analysed. Overall, the present study yielded promising results for a realistic implementation of an industrial prototype plasma source.
Inactivation of airborne bacteria by plasma treatment and ionic wind for indoor air cleaning
Airborne bacteria are a general problem in medical or health care facilities with a high risk for nosocomial infections. Rooms with a continuous airflow, such as operation theaters, are of particular importance due to a possible dissemination and circulation of pathogens including multidrug-resistant microorganisms. In this regard, a cold atmospheric-pressure plasma (CAP) may be a possibility to support usual disinfection procedures due to its decontaminating properties. The aim of this study was to determine the antimicrobial efficacy of a plasma decontamination module that included a dielectric barrier discharge for plasma generation. Experimental parameters such as an airflow velocity of 4.5 m/s and microbial contaminations of approximately 6,000 colony-forming units (cfu)/m3 were used to simulate practical conditions of a ventilation system in an operating theater. The apathogenic microorganism Escherichia coli K12 DSM 11250/NCTC 10538 and the multidrug-resistant strains E. coli 21181 and 21182 (isolated from patients) were tested to determine the antimicrobial efficacy. In summary, the number of cfu was reduced by 31–89% for the tested E. coli strains, whereby E. coli K12 was the most susceptible strain toward inactivation by the designed plasma module. A possible correlation between the number or kind of resistances and susceptibility against plasma was discussed. The inactivation of microorganisms was affected by plasma intensity and size of the plasma treatment area. In addition, the differences of the antimicrobial efficacies caused through the nebulization of microorganisms in front (upstream) or behind (downstream) the plasma source were compared. The presence of ionic wind had no influence on the reduction of the number of cfu for E. coli K12, as the airflow velocity was too high for a successful precipitation, which would be a prerequisite for an increased antimicrobial efficacy. The inactivation of the tested microorganisms confirms the potential of CAP for the improvement of air quality. The scale-up of this model system may provide a novel tool for an effective air cleaning process.